Health Care

New intelligent bionics and exoskeletons are expected to one day help patients who haven’t used their lower bodies in years.

When old medical debt is keeping you from moving ahead with your life, it's time to take action. 

Hundreds of thousands of children die from Malaria each year, but new research could help catch deadly diseases before they reach maturity.

The medical device maker reported improved earnings in the third quarter despite lagging sales of pacemakers and backed its full-year outlook.

To save as much as $2 billion a year, Teva Pharmaceutical said Thursday it was expanding its cost-cutting program by axing 10% of its workforce.

The moves are aimed at slimming down the global drug giant and narrowing its focus.

Oncolytics reported that its experimental lung cancer drug shrunk tumors in 92% of patients in a study.

Oncolytics reported that its experimental lung cancer drug shrunk tumors in 92% of patients in a study.

Isis Pharmaceuticals has once again joined forces with Biogen Idec to advance the treatment for neurological disorders.

Amgen said over the weekend it would  buy cancer drug maker Onyx Pharmaceuticals  for about $10.4 billion in one of the biggest-ever biotech deals.

St. Jude Medical agreed to buy Endosense for up to $230 million, providing it with catheter technologies that can be used during heart surgeries.

While health-related devices have yet to cause any catastrophes, the FDA and CIS are being proactive in trying to stop an attack before it happens.

Shares of MannKind climbed after the company revealed positive late-stage trial results for its experimental drug for type 1 and type 2 diabetes.

The biotech giant revealed positive results for a late-stage trial of a drug being investigated as a treatment for lung cancer.

Chronic disease challenges both health and wallet. Is there a way to cure the steep costs?

CVS Caremark's 2Q profit rose slightly more than expected, as profit growth at the pharmacy benefits management unit helped buoy modest improvements at the drugstores. 

All doctors aren’t created equal so it’s critical that people check out the credentials of their physician to ensure they’re getting the best treatment.

Fight for her Life: Kathy Giusti was diagnosed with a fatal cancer. Instead of giving up, she founded a non-profit that has grown into a key player in developing treatments for the rare blood disease. 

Patients looking for answers and advice from people suffering from similar problems have a new crop of social networks to check out.

Eli Lilly’s longtime CEO returned to his post after a nearly two-month medical leave as he recovered from a scheduled heart surgery.